002932.SZ
Wuhan Easy Diagnosis Biomedicine Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 14.31
−0.21%Year over year
Reported trailing growth
- Revenue
- -26.0%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +60.8%
- Operating cash flow
- +58.9%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -70.7%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +40.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026